News

Tesla's FSD 'Mad Max' Mode Faces Serious Safety Backlash

Tesla's FSD 'Mad Max' Mode Faces Serious Safety Backlash

Riding the Line of Recklessness

A storm's brewing over Tesla's latest venture into autonomous driving, and let me tell you, it’s not looking pretty. Ross Gerber from Gerber Kawasaki is waving a red flag over what he dubbed the ‘Mad Max’ mode of Tesla's FSD—Full Self-Driving features—and for good reason. This isn't just chatter from an investor; it's a serious warning that should have implications for anyone thinking about riding the Tesla wave.

‘Mad Max’ Mode Raises Eyebrows

Gerber came out swinging, pointing out that this new mode, introduced in the latest software update, is far from safe. We're talking about a driving profile that permits higher speeds and what Gerber describes as erratic lane changes. This isn’t just some overzealous feature meant for thrill-seekers; it's a recipe for disaster. He straightforwardly expressed, "Mad Max mode might actually kill someone as it drives too fast and erratic.” We all know Tesla has its loyal base, but how far will this blind support go when safety hangs in the balance?

“Tesla people seem triggered that I think it's a bad idea to have a self-driving profile that is basically unsafe.”

Legal Troubles Loom Large

One can't help but link this to Tesla's recent legal headaches. Just last week, a $240 million verdict slapped Tesla squarely in the face after a fatal incident involving their Autopilot system. Back in 2019, a Model S barreled through an intersection, killing a young man. A federal judge upheld the jury's ruling that Tesla was liable for this tragedy, citing evidence that supports the case against them. If that's not enough to put a chill down the spine of prospective buyers, I don't know what is.

Product Development Stagnation?

Look, it gets worse for Tesla. Gerber's hammering home that FSD improvements have hit a wall. Just a couple of days ago, he claimed "things don't seem to be improving" when it comes to FSD performance. Allegations surfaced about a Robotaxi fleet in Austin crashing multiple times in just one month. What’s going on back at HQ? It feels like they might be chasing a dream that’s just getting cloudier.

Competition and Regulation on the Horizon

Nothing livens up a sector like competition, and Tesla has no shortage of challengers on the horizon. With regulatory scrutiny tightening, how long can they afford to elbow their way through this haze? The National Highway Traffic Safety Administration is on them like white on rice, having opened a probe into almost 2.9 million vehicles over safety incidents. Throw in their “aggressive” driving modes, and it's clear that the FSD system isn’t just under the spotlight; it’s drowning in it.

Long-Term Implications for Investors

For investors grappling with the visibility of Tesla’s roadmap, it’s time to hit pause and reflect. If Gerber's warnings resonate, you might want to reconsider how much more the stock can realistically climb in light of looming legal and regulatory battles.

When you couple this with the rising competition from companies like Rivian and the likes of established giants pushing their electric line-ups, Tesla's once-dominant position may not be as secure as Musk might have everyone believe.

Looking Ahead: Is the Risk Worth the Reward?

The question remains: as an investor, should you trust a company seeming to toe the line of recklessness? Are they pushing the boundaries for innovation or just careening toward an accident waiting to happen? Gerber's comments and the financial fallout from litigation compel a deeper look into Tesla's long-term viability. It’s crucial you keep your eyes peeled for upcoming reports, regulatory updates, and any new developments surrounding their FSD software.

Investors should reflect on whether the potential rewards justify the mounting risks. Be smart, keep your ears to the ground, and wait for clarity on whether this wild ride is sustainable or just a high-speed chase toward trouble.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revolutionizing Fitness: Strength Training Trends for 2026

Updated Category News Views 138

Strength Training at the Core of Fitness Trends As the world embraces a new year, the fitness landscape is evolving significantly. The traditional approach of engaging primarily in cardio exercises to reach health goals is being left behind. This year, individuals are increasingly recognizing the myriad benefits of strength training. It has become the foundation upon...

Continue Reading
Armor Health Partners with CCNO to Enhance Care Services

Updated Category News Views 108

Armor Health Partners with CCNO to Enhance Care Services Armor Health, a leader in integrated correctional healthcare, has successfully taken over health services at the Corrections Center of Northwest Ohio. The transition marks a significant step for both the facility and Armor Health, ensuring that all correctional healthcare needs are met efficiently and...

Continue Reading
Evaluating Twist Bioscience's Upcoming Earnings Report

Updated Category News Views 151

Preparing for Twist Bioscience's Earnings Announcement Twist Bioscience (NASDAQ: TWST) is set to reveal its quarterly earnings report soon, creating significant anticipation among investors. This article will provide a comprehensive overview in anticipation of this crucial financial announcement. Market Expectations and Earnings Predictions Analysts project that Twist...

Continue Reading
Insights into Snap's Recent Options Activity and Market Position

Updated Category News Views 252

Insight into Snap's Recent Options Activity Investors are showing a strong bullish sentiment towards Snap (NYSE: SNAP), and this trend is something market watchers should pay attention to. Our thorough review of public option flows reveals significant trading patterns that often signal imminent market changes. We've observed an unparalleled surge in Snap options trading,...

Continue Reading
Canada's Potential Tariffs: A Response to U.S. Trade Actions

Updated Category News Views 250

Canada's Consideration of Retaliatory Tariffs Discussions are taking place in Canada regarding the imposition of retaliatory tariffs targeting a variety of U.S. goods, with orange juice being prominently mentioned. This potential move arises in response to the threat of a significant 25% tariff on imports from Canada, as suggested by newly elected officials in the United...

Continue Reading